Literature DB >> 7151768

Waterborne outbreak control: which disinfectant?

E W Akin, J C Hoff, E C Lippy.   

Abstract

Drinking water disinfection was shown to be an important public health measure around the turn of the century. In the United States, it was perhaps the single most important factor in controlling typhoid fever, a waterborne disease that was rampant throughout the world during the last century. It may also be assumed that disinfection was important in limiting the number of cases of other diseases known to be capable of waterborne transmission, i.e., cholera, amebiasis, shigellosis, salmonellosis, and hepatitis A. Even though modern treatment has eliminated water as a major vehicle of infectious disease transmission, outbreaks still occur. In fact, the annual number has been increasing since 1966. Interruption in chlorination or failure to achieve adequate levels of chlorine residual is the most often identified deficiency of the involved water supplies. This finding indicates that waterborne microbial pathogens remain as a potential health threat and underscores the importance of disinfection. From the outset, chlorination has been the drinking water disinfectant of choice in the country. Numerous studies have demonstrated its ability to inactivate bacterial, viral, and protozoal pathogens when applied under proper conditions. However, the finding that chlorinated organics that are potentially carcinogenic are formed has prompted an evaluation of alternative disinfectants. The viable alternatives to chlorine currently under consideration for widespread use are ozone, chlorine dioxide, and chloramines. In terms of biocidal efficiency, ozone is the most potent of the three. Chlorine dioxide is about the equivalent of free chlorine in the hypochlorous acid form but much more efficient than the hypochlorite form of free chlorine. The chloramines are weaker biocides than hypochlorite. Although this general order of ranking of efficiency holds for diverse types of microorganisms, quantitative comparisons vary with different microorganisms and experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151768      PMCID: PMC1569050          DOI: 10.1289/ehp.82467

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  6 in total

1.  Comparative inactivation of viruses by chlorine.

Authors:  R S Engelbrecht; M J Weber; B L Salter; C A Schmidt
Journal:  Appl Environ Microbiol       Date:  1980-08       Impact factor: 4.792

2.  Effect of ionic environment on the inactivation of poliovirus in water by chlorine.

Authors:  D G Sharp; D C Young; R Floyd; J D Johnson
Journal:  Appl Environ Microbiol       Date:  1980-03       Impact factor: 4.792

3.  Inactivation of coxsackieviruses B3 and B5 in water by chlorine.

Authors:  H Jensen; K Thomas; D G Sharp
Journal:  Appl Environ Microbiol       Date:  1980-09       Impact factor: 4.792

4.  Inactivation of poliovirus I (Brunhilde) single particles by chlorine in water.

Authors:  D G Sharp; J Leong
Journal:  Appl Environ Microbiol       Date:  1980-08       Impact factor: 4.792

5.  Efficiency of chlorine dioxide as a bactericide.

Authors:  M A Benarde; B M Israel; V P Olivieri; M L Granstrom
Journal:  Appl Microbiol       Date:  1965-09

6.  Effect of chlorine on Giardia lamblia cyst viability.

Authors:  E L Jarroll; A K Bingham; E A Meyer
Journal:  Appl Environ Microbiol       Date:  1981-02       Impact factor: 4.792

  6 in total
  3 in total

1.  Legionella: A Promising Supplementary Indicator of Microbial Drinking Water Quality in Municipal Engineered Water Systems.

Authors:  Chiqian Zhang; Jingrang Lu
Journal:  Front Environ Sci       Date:  2021-11-10

Review 2.  Toxicological effects of chlorine dioxide, chlorite and chlorate.

Authors:  D Couri; M S Abdel-Rahman; R J Bull
Journal:  Environ Health Perspect       Date:  1982-12       Impact factor: 9.031

3.  Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul.

Authors:  Ahmad Fawad Jebran; Ulrike Schleicher; Reto Steiner; Pia Wentker; Farouq Mahfuz; Hans-Christian Stahl; Faquir Mohammad Amin; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.